Trials / Completed
CompletedNCT05586620
3 Snip Punctoplasty With and Without Mitomycine C.
Comparative Study on 3 Snip Punctoplasty With and Without Mitomycine C in the Management of Punctual Stenosis or Occlusion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 16 Years – 63 Years
- Healthy volunteers
- Not accepted
Summary
Punctal stenosis is a progressive constriction of the puncta with resultant epiphora. One of the most effective treatment options is 1- to 4-snip punctoplasty combined with or without Mitomycin-C.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 3-snip punctoplasty | punctoplasty, more commonly known as watery eye surgery, is an ophthalmic surgical procedure performed to correct punctal stenosis (a condition that causes tears to overflow from the eyes) by widening the punctal opening to allow the tears to drain with ease. |
| PROCEDURE | 3-snip punctoplasty and Mitomycin C | punctoplasty, more commonly known as watery eye surgery, is an ophthalmic surgical procedure performed to correct punctal stenosis (a condition that causes tears to overflow from the eyes) by widening the punctal opening to allow the tears to drain with ease. Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2022-06-01
- Completion
- 2022-06-10
- First posted
- 2022-10-19
- Last updated
- 2022-10-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05586620. Inclusion in this directory is not an endorsement.